Study on the Sensitivity of Combined Chemotherapy Regimens for AML in Vitro and in Vivo

李慧慧,汤爱萍,杨碧云,曹瑞生,石庆之,杨桂玲,陈三军,华建媛
DOI: https://doi.org/10.3969/j.issn.1000-2294.2004.04.015
2004-01-01
Abstract:Objective To explore the sensitivity of combined chemotherapy regimens for AML in vivo and in vitro.Methods The effect of chemotherapeutic drugs in AML cells was investigated by MTT assay,“multiplicative” model and the ”maximum” model analysis method.Results (1).Thirty-five of fifty-seven (61%) patients were sensitive to HA,33(58%) sensitive to DA,33(58%)sensitive to MA.(2).synergism and antagonism was 72% between HHT and Ara-c,74% between DNR and Ara-c,74%between MTZ and Ara-c.There were 39 patients were judged the clinical effect,S/S 19 cases,S/R 6 case ,R/R 11cases,R/S 3 cases(S:sensitivity,R:resistance,in vitro/in vivo).The general coincident rate of in vitro and in vivo was 76.9%.Conclusion The combined chemotherapy regimens such as HA、DA and MA would be effective regimens for AML patients.There is synergism or additive among most of chemotherapy regimens,which is similar to the rate of clinical remission.
What problem does this paper attempt to address?